Roflumilast
Roflumilast is a medication commonly known by the brand name Daxas. It is a targeted treatment designed to address inflammation associated with Chronic Obstructive Pulmonary Disease. Daliresp is available to support individuals managing these respiratory symptoms. This preparation is a primary option for people seeking sustained relief from chronic airway issues.
Key points
- Intended for long-term maintenance rather than as a rescue treatment during a sudden breathing attack.
- Works by raising cyclic AMP levels inside inflammatory cells, which reduces inflammation in the lungs over time.
- A history of depression or significant liver problems may make this medicine less suitable, and unintended weight loss should be monitored early in treatment.
- Reduces how often flare-ups occur in chronic obstructive pulmonary disease by targeting the airway inflammation behind them.
What is Roflumilast?
Roflumilast is a selective phosphodiesterase-4 (PDE4) inhibitor used to manage chronic inflammatory conditions in the airways. By targeting the underlying inflammation, it serves as a long-term maintenance treatment rather than a rescue medication for sudden episodes. It provides a distinct approach to therapy when other standard therapies are insufficient.
What Roflumilast is used for
This medication is primarily indicated for the management of Chronic Obstructive Pulmonary Disease. It works to reduce the frequency of exacerbations or flare-ups, helping stabilise breathing for individuals living with long-term obstructive airway issues. It is not intended to treat acute asthma attacks or immediate breathing difficulties.
How does Roflumilast work?
Roflumilast works by blocking an enzyme called PDE4, which is found in inflammatory cells. Inhibiting this enzyme increases levels of cyclic AMP within these cells, which effectively puts the brakes on the inflammatory process in your lungs. Reducing this cellular inflammation helps improve overall airflow and limits the tissue damage that leads to worsening symptoms over time.
Roflumilast brands and forms
Patients have access to established brand formulations such as Daxas and Daliresp, which are formulated as specific strengths for daily oral use. These options fall under the broader category of Respiratory Health treatments. Our current catalogue presents the film-coated tablet formulation designed for consistent absorption. Choosing between brands often depends on regional availability and specific doctor recommendations.
Safety overview for Roflumilast
What to check before using this medicine
Ensure that you have discussed your complete medical history with your healthcare provider, particularly if you have a history of depression, liver impairment, or underweight conditions. Roflumilast may not be suitable for people with specific pre-existing mental health concerns or severe liver issues.
Possible reactions and tolerability
Some individuals may experience common effects such as nausea, diarrhoea, or changes in sleep patterns when starting the medication. These digestive symptoms often subside as your body adjusts to the therapy over the first few weeks. Monitor your weight, as unintentional weight loss can sometimes occur during initial treatment phases.
Interactions and health factors
Certain medications, including those used for epilepsy or strong anti-infective drugs, may interfere with how your body clears Roflumilast. Always declare all concurrent supplements and medications to your doctor. Product labelling and verified clinical sources remain the correct references for specific contraindications, interactions and reactions.